Traditional Chinese medicine composition for allergic rhinitis and Yupingfeng anti-allergic preparation

Abstract

The invention discloses a traditional Chinese medicine composition for allergic rhinitis. The traditional Chinese medicine composition comprises the following raw materials by weight: 15-40 g of bighead atractylodes rhizome, 10-20 g of astragalus membranaceus, 6-20 g of dark plum, 9-20 g of radices sileris, 3-9 g of fructus xanthii, 6-15 g of flos magnoliae, 6-15 g of angelica dahurica and 3-9 g of mint. Preferably, the traditional Chinese medicine composition comprises the following raw materials by weight: 30 g of bighead atractylodes rhizome, 15 g of astragalus membranaceus, 15 g of dark plum, 15 g of radices sileris, 6 g of fructus xanthii, 10 g of flos magnoliae, 10 g of angelica dahurica and 6 g of mint. The invention further discloses a Yupingfeng anti-allergic nasal wash or a Yupingfeng anti-allergic nasal spray prepared from the traditional Chinese medicine composition. The Yupingfeng anti-allergic nasal wash or the Yupingfeng anti-allergic nasal spray prepared from the eighttraditional Chinese medicines according to the formula ratio has a significant short-term treatment effect when being used for treating the allergic rhinitis and particularly has a significant improvement in nasal obstruction, running nose, sternutation, itchy nose, itchy eyes and the like. The traditional Chinese medicine composition disclosed by the invention adopts intranasal administration, not only is convenient to use, but also can achieve the advantages of good treatment effect, quick effect and safety and overcome the defects of low medicine efficacy, slow effect and inconvenient use of an existing oral preparation.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for allergic rhinitis and a jade screen antiallergic preparation. Background technique [0002] In recent years, there have been more and more patients with allergic rhinitis in our country, and the prevalence rate in the population in mainland China has reached 4%-38%, and the incidence rate has been showing an obvious upward trend in the past 30 years. [0003] At present, there are many kinds of drugs for the treatment of allergic rhinitis, among which oral preparations account for the vast majority, and external preparations are rare. The clinical medication guidelines emphasize the treatment plan based on the principle of "combination of prevention and treatment, four in one", in which drugs and desensitization therapy are used as the first-line treatment. Nasal corticosteroids, nasal or oral antihistamines, and leukotri...

AI Technical Summary

Problems solved by technology

These are problems that cannot be effectively solved at present

[0004] This shows that the above-mentioned existing medicine for the treatment of allergic rhinitis still has deficiencies, and urgently needs to be further improved.

Images